Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 496 IDR 2.9% Market Closed
Market Cap: 5.6T IDR

Pyridam Farma Tbk PT
Total Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Pyridam Farma Tbk PT
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
Total Receivables
Rp854.3B
CAGR 3-Years
69%
CAGR 5-Years
74%
CAGR 10-Years
38%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Total Receivables
Rp1.7T
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
6%
Kalbe Farma Tbk PT
IDX:KLBF
Total Receivables
Rp5.8T
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
8%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Total Receivables
Rp779.1B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
7%
Soho Global Health Tbk PT
IDX:SOHO
Total Receivables
Rp2.1T
CAGR 3-Years
25%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Total Receivables
Rp1.6T
CAGR 3-Years
-16%
CAGR 5-Years
-6%
CAGR 10-Years
6%
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
5.6T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
499.62 IDR
Undervaluation 1%
Intrinsic Value
Price

See Also

What is Pyridam Farma Tbk PT's Total Receivables?
Total Receivables
854.3B IDR

Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Total Receivables amounts to 854.3B IDR.

What is Pyridam Farma Tbk PT's Total Receivables growth rate?
Total Receivables CAGR 10Y
38%

Over the last year, the Total Receivables growth was 38%. The average annual Total Receivables growth rates for Pyridam Farma Tbk PT have been 69% over the past three years , 74% over the past five years , and 38% over the past ten years .

Back to Top